Skip to content

Kinesin-like protein KIF13B (KIF13B)

Homo sapiens — UniProt Q9NQT8

Gene: KIF13BHomo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Kinesin-like protein KIF13B (KIF13B) is a protein from Homo sapiens identified by UniProt accession Q9NQT8, 1826 residues long. MolForge cross-references it against 0 known binders and 44 disease associations.

  • UniProt accession: Q9NQT8; gene symbol KIF13B.
  • Organism: Homo sapiens.
  • Length: 1826 amino acids.
  • Top disease associations (Open Targets): low density lipoprotein cholesterol measurement, apolipoprotein B measurement and total cholesterol measurement.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameKinesin-like protein KIF13B
UniProt accessionQ9NQT8
GeneKIF13B
OrganismHomo sapiens
Length1826 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (44)

Diseases linked to this target (Open Targets).

  • low density lipoprotein cholesterol measurement · score 0.36
  • apolipoprotein B measurement · score 0.28
  • total cholesterol measurement · score 0.28
  • low grade glioma · score 0.18
  • breast adenocarcinoma · score 0.18
  • esophageal cancer · score 0.15
  • BMI-adjusted waist circumference · score 0.11
  • mammographic density percentage · score 0.08
  • hypertriglyceridemia 2 · score 0.08
  • cholesterol-ester transfer protein deficiency · score 0.08

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9NQT8-F1alphafoldPREDICTED67.10—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9NQT8.

Amino-acid sequence (1826 residues)

MGDSKVKVAV RIRPMNRRET DLHTKCVVDV DANKVILNPV NTNLSKGDAR GQPKVFAYDH CFWSMDESVK EKYAGQDIVF KCLGENILQN AFDGYNACIF AYGQTGSGKS YTMMGTADQP GLIPRLCSGL FERTQKEENE EQSFKVEVSY MEIYNEKVRD LLDPKGSRQT LKVREHSVLG PYVDGLSKLA VTSYKDIESL MSEGNKSRTV AATNMNEESS RSHAVFKITL THTLYDVKSG TSGEKVGKLS LVDLAGSERA TKTGAAGDRL KEGSNINKSL TTLGLVISAL ADQSAGKNKN KFVPYRDSVL TWLLKDSLGG NSKTAMVATV SPAADNYDET LSTLRYADRA KHIVNHAVVN EDPNARIIRD LREEVEKLRE QLTKAEAMKS PELKDRLEES EKLIQEMTVT WEEKLRKTEE IAQERQKQLE SLGISLQSSG IKVGDDKCFL VNLNADPALN ELLVYYLKEH TLIGSANSQD IQLCGMGILP EHCIIDITSE GQVMLTPQKN TRTFVNGSSV SSPIQLHHGD RILWGNNHFF RLNLPKKKKK AEREDEDQDP SMKNENSSEQ LDVDGDSSSE VSSEVNFNYE YAQMEVTMKA LGSNDPMQSI LNSLEQQHEE EKRSALERQR LMYEHELEQL RRRLSPEKQN CRSMDRFSFH SPSAQQRLRQ WAEEREATLN NSLMRLREQI VKANLLVREA NYIAEELDKR TEYKVTLQIP ASSLDANRKR GSLLSEPAIQ VRRKGKGKQI WSLEKLDNRL LDMRDLYQEW KECEEDNPVI RSYFKRADPF YDEQENHSLI GVANVFLESL FYDVKLQYAV PIINQKGEVA GRLHVEVMRL SGDVGERIAG GDEVAEVSFE KETQENKLVC MVKILQATGL PQHLSHFVFC KYSFWDQQEP VIVAPEVDTS SSSVSKEPHC MVVFDHCNEF SVNITEDFIE HLSEGALAIE VYGHKINDPR KNPALWDLGI IQAKTRSLRD RWSEVTRKLE FWVQILEQNE NGEYCPVEVI SAKDVPTGGI FQLRQGQSRR VQVEVKSVQE SGTLPLMEEC ILSVGIGCVK VRPLRAPRTH ETFHEEEEDM DSYQDRDLER LRRKWLNALT KRQEYLDQQL QKLVSKRDKT EDDADREAQL LEMRLTLTEE RNAVMVPSAG SGIPGAPAEW TPVPGMETHI PVIFLDLNAD DFSSQDNLDD PEAGGWDATL TGEEEEEFFE LQIVKQHDGE VKAEASWDSA VHGCPQLSRG TPVDERLFLI VRVTVQLSHP ADMQLVLRKR ICVNVHGRQG FAQSLLKKMS HRSSIPGCGV TFEIVSNIPE DAQGVEEREA LARMAANVEN PASADSEAYI EKYLRSVLAV ENLLTLDRLR QEVAVKEQLT GKGKLSRRSI SSPNVNRLSG SRQDLIPSYS LGSNKGRWES QQDVSQTTVS RGIAPAPALS VSPQNNHSPD PGLSNLAASY LNPVKSFVPQ MPKLLKSLFP VRDEKRGKRP SPLAHQPVPR IMVQSASPDI RVTRMEEAQP EMGPDVLVQT MGAPALKICD KPAKVPSPPP VIAVTAVTPA PEAQDGPPSP LSEASSGYFS HSVSTATLSD ALGPGLDAAA PPGSMPTAPE AEPEAPISHP PPPTAVPAEE PPGPQQLVSP GRERPDLEAP APGSPFRVRR VRASELRSFS RMLAGDPGCS PGAEGNAPAP GAGGQALASD SEEADEVPEW LREGEFVTVG AHKTGVVRYV GPADFQEGTW VGVELDLPSG KNDGSIGGKQ YFRCNPGYGL LVRPSRVRRA TGPVRRRSTG LRLGAPEARR SATLSGSATN LASLTAALAK ADRSHKNPEN RKSWAS

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with KIF13B?

The strongest Open Targets associations for KIF13B are low density lipoprotein cholesterol measurement, apolipoprotein B measurement, total cholesterol measurement, low grade glioma and breast adenocarcinoma.

How long is the KIF13B protein?

The Homo sapiens KIF13B protein (UniProt Q9NQT8) is 1826 amino acids long.

Browse: Targets: K · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Kinesin-like protein KIF13B with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9NQT8
GeneKIF13B
OrganismHomo sapiens
Length1826
Binders0
Diseases44
View on UniProt